This inventor holds 40 USPTO granted patents, plus 3 CIPO patents and 2 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Theravance, Inc., Theravance Biopharma R&d IP, LLC. Active years: 2004-2018.
Location History:
- Pacifica, CA (US) (2004 - 2010)
- San Francisco, CA (US) (2005 - 2012)
- Reston, VA (US) (2011 - 2018)
Company Filing History:
Years Active: 2004-2018
Areas of Expertise:
Title: Innovations by S Derek Turner in the Field of Pharmacology
Introduction
S Derek Turner, located in San Francisco, CA, is a prolific inventor with an impressive portfolio of 40 patents. His work primarily focuses on the development of novel compounds aimed at advancing pharmacological treatments. His inventions reflect a commitment to enhancing therapeutic options in the realm of mental health and neuropharmacology.
Latest Patents
Among Turner’s latest innovations are his patents concerning quinolinone-carboxamide compounds as 5-HT4 receptor agonists. This groundbreaking invention provides novel quinolinone-carboxamide 5-HT receptor agonist compounds. It further encompasses pharmaceutical compositions that utilize these compounds, methods for employing them to treat diseases linked to 5-HT receptor activity, and detailed processes and intermediates for synthesizing these beneficial compounds.
Career Highlights
S Derek Turner has made significant contributions to the field through his roles at prominent companies. He has worked at Theravance, Inc. and Theravance Biopharma R&D IP, LLC, where he has been instrumental in developing innovative solutions that address critical healthcare needs. His extensive experience in pharmaceutical research has positioned him as a leading figure in his domain.
Collaborations
Turner has collaborated with notable peers, including Paul Ross Fatheree and Daniel Marquess. These professional associations have fostered a dynamic exchange of ideas and have played an essential role in the development of his innovative patents.
Conclusion
With a remarkable array of patents and a dedication to improving pharmacological treatments, S Derek Turner stands out as a significant figure in the field of medical innovation. His work continues to contribute to advancements in therapies targeting 5-HT receptor activity, demonstrating both his ingenuity and commitment to healthcare improvement.